On June 23, 2023, Relief Therapeutics Holding AG closed the transaction. The company issued 1,200,000 common shares at an issue price of CHF 3.330 per share for gross proceeds of 3,996,000 and 300,000 pre-funded warrants at an issue price of 3.3290 for gross proceeds of CHF 998,700 for aggregate gross proceeds of CHF 4,994,700 along with 1,500,000 warrants. The transaction included participation from a healthcare-focused institutional investor.

The pre-funded warrants will expire upon exercise at an exercise price of CHF 0.0010 per warrant. The warrants are immediately exercisable and will expire in five years at an exercise price of CHF 3.40 per share.